Latest News

February 27, 2014
As the worlds of health care, research and higher education undergo seismic economic shifts, UC San Francisco is uniquely well positioned to excel and even capitalize on the changes, University leaders say.
February 26, 2014
Over the past 18 months, physicians in California have observed on rare occasions what may be a new disease, one in which patients, usually children, quickly and permanently lose muscle function in an arm or leg.
February 26, 2014
Researchers worldwide will now have access to genetic data linked to medical information on a diverse group of more than 78,000 people, enabling investigations into many diseases and conditions.
February 25, 2014
UCSF and Walgreens have opened a unique Walgreens store that aims to improve medication safety, decrease health care costs and help patients use medicines more effectively.
February 24, 2014
First-year UCSF medical student Jeffrey Chen gives a first-person account of a night he volunteered for the UCSF Homeless Clinic at the St. Vincent de Paul Society of San Francisco.
February 23, 2014
Scientists at the Gladstone Institutes and UCSF have made an important breakthrough: they have discovered a way to transform skin cells into mature, fully functioning liver cells that flourish.
February 21, 2014
Samsung Electronics Co., Ltd., and UC San Francisco have announced a partnership to accelerate validation and commercialization of promising new sensors, algorithms, and digital health technologies for preventive health solutions.
February 20, 2014
Scientists at the UCSF-affiliated Gladstone Institutes have devised a new method that allows for the more efficient and complete reprogramming of skin cells into cells that are virtually indistinguishable from heart muscle cells.
February 20, 2014
A group of five UC San Francisco graduate students and a postdoctoral scholar won a national video competition called “Stand Up for Science" to convey the importance of basic science research.
February 19, 2014
Genetic testing can help doctors choose the most effective and economical drugs to prevent blood clots in the half a million patients in the U.S. who receive coronary stents each year, according to a new study led by a UCSF researcher.

Pages